Vascular Disrupting Agents in Cancer Therapy
作者： Gillian M. Tozer , Chryso Kanthou , David J. Chaplin
DOI: 10.1007/978-3-540-33177-3_45
关键词: Clinical trial 、 Cancer research 、 Actin cytoskeleton 、 Dosing schedules 、 Vascular collapse 、 Treatment resistance 、 Vascular endothelial growth factor 、 Cancer therapy 、 Tumour tissue 、 Medicine
摘要: Tumor blood vessel formation is a key process for tumor expansion. Tumor vessels are abnormal and differ from normal vessels in architecture and components. Besides oxygen and …
springer.com
springerlink.com参考文章(51)
Orest W. Blaschuk, Cadherins as modulators of angiogenesis and the structural integrity of blood vessels. Cancer and Metastasis Reviews. ,vol. 19, pp. 1- 5 ,(2000) , 10.1023/A:1026522216059
George Pettit, D. J. Swaine, P. M. Loadman, K. Grosios, M. C. Bibby, Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinoma. Anticancer Research. ,vol. 20, pp. 229- 233 ,(2000)
Bruce C. Baguley, Wayne R. Joseph, Lai-Ming Ching, David Goldsmith, Jonathon D. Sedgwick, Heinrich Körner, Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice. Cancer Research. ,vol. 59, pp. 3304- 3307 ,(1999)
Young S. Lew, Chang W. Song, Robert J. Griffin, Stephen L. Brown, Jae Ho Kim, Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown. Cancer Research. ,vol. 59, pp. 6033- 6037 ,(1999)
Bruce C. Baguley, Lai-Ming Ching, Philip Kestell, Liangli Zhao, Improvement of the Antitumor Activity of Intraperitoneally and Orally Administered 5,6-Dimethylxanthenone-4-Acetic Acid by Optimal Scheduling Clinical Cancer Research. ,vol. 9, pp. 6545- 6550 ,(2003)
Katsuyoshi Hori, Sachiko Saito, Yukio Nihei, Manabu Suzuki, Yasufumi Sato, Antitumor Effects due to Irreversible Stoppage of Tumor Tissue Blood Flow: Evaluation of a Novel Combretastatin A-4 Derivative, AC7700 Japanese Journal of Cancer Research. ,vol. 90, pp. 1026- 1038 ,(1999) , 10.1111/J.1349-7006.1999.TB00851.X
CJ Lash, AE Li, M Rutland, BC Baguley, LJ Zwi, WR Wilson, Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs British Journal of Cancer. ,vol. 78, pp. 439- 445 ,(1998) , 10.1038/BJC.1998.512
Yukio Nihei, Manabu Suzuki, Akira Okano, Takashi Tsuji, Yukio Akiyama, Takashi Tsuruo, Sachiko Saito, Katsuyoshi Hori, Yasufumi Sato, Evaluation of Antivascular and Antimitotic Effects of Tubulin Binding Agents in Solid Tumor Therapy Japanese Journal of Cancer Research. ,vol. 90, pp. 1387- 1395 ,(1999) , 10.1111/J.1349-7006.1999.TB00724.X
Dietmar W. Siemann, Emma Mercer, Sharon Lepler, Amyn M. Rojiani, Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy International Journal of Cancer. ,vol. 99, pp. 1- 6 ,(2002) , 10.1002/IJC.10316
Shiladitya Sengupta, David Eavarone, Ishan Capila, Ganlin Zhao, Nicki Watson, Tanyel Kiziltepe, Ram Sasisekharan, Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature. ,vol. 436, pp. 568- 572 ,(2005) , 10.1038/NATURE03794